iasibon
pharmathen s.a. - ibandronsyre - hypercalcemia; fractures, bone; neoplasm metastasis; breast neoplasms - narkotika til behandling af knoglesygdomme - concentrate for solution for infusion prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases. behandling af tumor-induceret hypercalcaemia med eller uden metastaser. film-coated tablets prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with breast cancer and bone metastases.
ibandronsyre "fresenius kabi" 3 mg injektionsvæske, opløsning, fyldt injektionssprøjte
fresenius kabi ab - ibandronsyre - injektionsvæske, opløsning, fyldt injektionssprøjte - 3 mg
optinate septimum 35 mg filmovertrukne tabletter
theramex ireland limited - risedronsyre - filmovertrukne tabletter - 35 mg
pamidronatdinatrium "pfizer" 3 mg/ml koncentrat til infusionsvæske, opløsning
pfizer aps - pamidronsyre, vandfrit - koncentrat til infusionsvæske, opløsning - 3 mg/ml
pamidronatdinatrium "pfizer" 6 mg/ml koncentrat til infusionsvæske, opløsning
pfizer aps - pamidronsyre, vandfrit - koncentrat til infusionsvæske, opløsning - 6 mg/ml
pamidronatdinatrium "pfizer" 9 mg/ml koncentrat til infusionsvæske, opløsning
pfizer aps - pamidronsyre, vandfrit - koncentrat til infusionsvæske, opløsning - 9 mg/ml
pamidronat "hexal" 15 mg/ml koncentrat til infusionsvæske, opløsning
hexal ag - pamidronsyre - koncentrat til infusionsvæske, opløsning - 15 mg/ml
pamifos 3 mg/ml koncentrat til infusionsvæske, opløsning
medac, gesellschaft für klinische spezialpräparate mbh - pamidronsyre - koncentrat til infusionsvæske, opløsning - 3 mg/ml
adempas
bayer ag - riociguat - hypertension, lunge - antihypertensive midler til pulmonal arteriel hypertension - chronic thromboembolic pulmonary hypertension (cteph)adempas is indicated for the treatment of adult patients with who functional class (fc) ii to iii withinoperable cteph,persistent or recurrent cteph after surgical treatment,to improve exercise capacity. pulmonary arterial hypertension (pah)adultsadempas, as monotherapy or in combination with endothelin receptor antagonists, is indicated for the treatment of adult patients with pulmonary arterial hypertension (pah) with who functional class (fc) ii to iii to improve exercise capacity. effekten har været vist i en pah befolkningen, herunder aetiologies af idiopatisk eller arvelige pah eller pah, der er forbundet med bindevævssygdom. paediatricsadempas is indicated for the treatment of pah in paediatric patients aged less than 18 years of age and body weight ≥ 50 kg with who functional class (fc) ii to iii in combination with endothelin receptor antagonists.
ibandronat "actavis" 150 mg filmovertrukne tabletter
actavis group ptc ehf. - natriumibandronatmonohydrat - filmovertrukne tabletter - 150 mg